Revolution Medicines, Inc. (RVMDW) Capital expenditures 2018–2025
Revolution Medicines, Inc. (RVMDW) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$16.0MFY2025 · since FY2018: $1.5M → $16.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $16.0M | +55.1% |
| FY2024 | $10.3M | +33.4% |
| FY2023 | $7.7M | -28.5% |
| FY2022 | $10.8M | +65.7% |
| FY2021 | $6.5M | +122.6% |
| FY2020 | $2.9M | +13.3% |
| FY2019 | $2.6M | +72.7% |
| FY2018 | $1.5M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice